Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C27H29NO11 |
Molecular Weight | 543.5193 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]2C[C@@](O)(CC3=C(O)C4=C(C(=O)C5=C(OC)C=CC=C5C4=O)C(O)=C23)C(=O)CO
InChI
InChIKey=AOJJSUZBOXZQNB-TZSSRYMLSA-N
InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22+,27-/m0/s1
Molecular Formula | C27H29NO11 |
Molecular Weight | 543.5193 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 6 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:21:26 UTC 2023
by
admin
on
Fri Dec 15 17:21:26 UTC 2023
|
Record UNII |
80168379AG
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000007530
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
||
|
FDA ORPHAN DRUG |
199904
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
||
|
FDA ORPHAN DRUG |
276009
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
||
|
FDA ORPHAN DRUG |
553116
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
||
|
FDA ORPHAN DRUG |
820821
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
||
|
NDF-RT |
N0000007530
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
8.2
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
||
|
FDA ORPHAN DRUG |
248107
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
||
|
FDA ORPHAN DRUG |
469215
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
||
|
FDA ORPHAN DRUG |
844921
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
||
|
FDA ORPHAN DRUG |
808521
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
||
|
WHO-VATC |
QL01DB01
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
||
|
NDF-RT |
N0000000176
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
||
|
NDF-RT |
N0000007530
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
||
|
FDA ORPHAN DRUG |
139800
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
||
|
FDA ORPHAN DRUG |
286109
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
||
|
NCI_THESAURUS |
C67502
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
||
|
NDF-RT |
N0000175414
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
||
|
FDA ORPHAN DRUG |
117398
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
||
|
LIVERTOX |
NBK548622
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/15/1513
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
||
|
WHO-ATC |
L01DB01
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID8021480
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY | |||
|
3639
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY | RxNorm | ||
|
CHEMBL53463
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY | |||
|
SUB35582
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY | |||
|
7069
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY | |||
|
960
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY | |||
|
Doxorubicin
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY | |||
|
23214-92-8
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY | |||
|
245-495-6
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY | |||
|
123127
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY | |||
|
D004317
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY | |||
|
80168379AG
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY | |||
|
759155
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY | |||
|
80168379AG
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY | |||
|
DB00997
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY | |||
|
100000085265
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY | |||
|
28748
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY | |||
|
3005
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY | |||
|
DOXORUBICIN
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY | |||
|
C456
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY | |||
|
64816
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY | |||
|
m4757
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY | Merck Index | ||
|
SUB06391MIG
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY | |||
|
31703
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY | |||
|
3070
Created by
admin on Fri Dec 15 17:21:26 UTC 2023 , Edited by admin on Fri Dec 15 17:21:26 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BINDER->LIGAND |
BINDING
|
||
|
TRANSPORTER -> SUBSTRATE | |||
|
TRANSPORTER -> SUBSTRATE |
Dogs homozygous or heterozygous for the ABCB1-1Δ mutation are significantly more likely than normal dogs to develop haematological and gastrointestinal toxicity.
|
||
|
TARGET -> INHIBITOR |
BINDING
|
||
|
TRANSPORTER -> SUBSTRATE | |||
|
TRANSPORTER -> SUBSTRATE |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
TRANSPORTER -> SUBSTRATE |
Responsible for the resistance to doxorubicin of a subset of malignant melanomas.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
MAJOR
|
||
|
PRODRUG -> METABOLITE ACTIVE |
Reacts with the Cys-34 of albumin gets transported to tumor microenvironment and released in acidic environment.
|
||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||